Monitoring Immunotherapy Toxicities in CSCC and BCC

Dr. Vishal Anil  Patel, MD, Director of  Cutaneous Oncology and Dermatologic Surgery,  is featured in an article emphasizing the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC. For more information, please click here.